Organogenesis Holdings
ORGO
156 hedge funds and large institutions have $441M invested in Organogenesis Holdings in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 68 increasing their positions, 45 reducing their positions, and 25 closing their positions.
51% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 45
1.55% more ownership
Funds ownership: 43.41% → 44.96% (+1.5%)
0% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 25
1% less funds holding
Funds holding: 157 → 156 (-1)
14% less capital invested
Capital invested by funds: $514M → $441M (-$72.7M)
22% less call options, than puts
Call options by funds: $665K | Put options by funds: $854K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$10.9M |
| 2 |
Morgan Stanley
New York
|
+$10.3M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$7.31M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.49M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$4.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$17.5M |
| 2 |
State Street
Boston,
Massachusetts
|
-$7.59M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.15M |
| 4 |
NMIMC
Northwestern Mutual Investment Management Company
Milwaukee,
Wisconsin
|
-$2.22M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$2.07M |
ORGO Hedge Fund Activity: Q1 2022 in Review
156 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q1 2022, worth a combined $441M — down 14% from $514M a quarter earlier.
Fund positioning in ORGO was balanced in Q1 2022: 25 funds opened new positions, 25 closed out, 68 added to existing stakes and 45 trimmed.
The largest buyer was BlackRock, adding an estimated $10.9M. The largest seller was Macquarie Group, cutting an estimated $17.5M.
- 156 institutional investors held Organogenesis Holdings (ORGO) as of Q1 2022, down from 157 in Q4 2021.
- Funds reported $441M of Organogenesis Holdings stock for Q1 2022, down 14% quarter-over-quarter.
- 25 funds opened new Organogenesis Holdings positions in Q1 2022 and 25 closed out, a net change of 0 holders.
- The largest Organogenesis Holdings buyer in Q1 2022 was BlackRock, an estimated $10.9M added.
- The largest Organogenesis Holdings seller in Q1 2022 was Macquarie Group, an estimated $17.5M sold.
Based on aggregated 13F filings for Q1 2022.